MassMutual Premier Funds
Abbott subsidiary Alere pays $160M to settle false Medicare claims, diabetes kickbacks | Fierce Biotech
Abbott Labs Deal Headaches Go Beyond Bad Luck - Bloomberg
Proxy Statement for 2022 Annual Meeting of Stockholders
Mml Series Investment Fund Ii 2013 Semi-Annual Certified Shareholder Report N-CSRS
Abbott moves ahead on St. Jude, Alere deals, but investors fret | Reuters
Global Health Governance
Abbott files complaint to end Alere acquisition deal
QDEL 03.31.2022 Earnings Call Script
After roller-coaster year, Abbott moves to close Alere deal | Fierce Biotech
2009 General Corporation Tax Allocation Percentage ... - NYC.gov
Abbott Acquisition of Alere Set to Close on Tuesday, October 3, 2017 - Sep 29, 2017
HRM Asia Magazine November/December 2021 Issue by HRM Asia - Issuu
Pulse of the industry
Pulse of the industry
Abbott Labs Deal for Alere Shows Good Timing - Bloomberg
VOLUME 37 NUMBER 11
November | 2012 | Leaders in Pharmaceutical Business Intelligence (LPBI) Group
Point-of-care diagnostics for infectious diseases: From methods to devices. - Abstract - Europe PMC
Abbott and Alere, After Lawsuits, Agree to Make Up and Tie the Knot - The New York Times
